All data are based on the daily closing price as of March 20, 2026
b
BioNote
377740.KO
3.63 USD
0.06
+1.68%
Overview
Last close
3.63 usd
Market cap
367.60M usd
52 week high
4.47 usd
52 week low
2.83 usd
Target price
3.79 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
4.785
Price/Book Value
0.3235
Enterprise Value
135.70M usd
EV/Revenue
1.7747
EV/EBITDA
1.4329
Key financials
Revenue TTM
76.46M usd
Gross Profit TTM
42.51M usd
EBITDA TTM
18.10M usd
Earnings per Share
N/A usd
Dividend
0.15 usd
Total assets
1.25B usd
Net debt
N/A usd
About
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.